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Caenorhabditis elegans F09E10.3 (dhs-25) was identiﬁed as encoding a 3-oxoacyl-thioester reductase, potentially of the
mitochondrial type 2 fatty acid synthase (FASII) system. Mitochondrial FASII is a relatively recent discovery in metazoans, and
the relevance of this process to animal physiology has not been elucidated. A good animal model to study the role of FASII is the
nematodeC.elegans.However,thecomponentsofnematodemitochondrialFASIIhavehithertoevadedpositiveidentiﬁcation.The
nematode F09E10.3 protein was ectopically expressed without an additional mitochondrial targeting sequence in Saccharomyces
cerevisiae mutant cells lacking the homologous mitochondrial FASII enzyme 3-oxoacyl-ACP reductase Oar1p. These yeast oar1Δ
mutants are unable to respire, grow on nonfermentable carbon sources, or synthesize suﬃcient levels of lipoic acid. Mutant yeast
cells producing a full-length mitochondrial F09E10.3 protein contained NAD
+-dependent 3-oxoacyl-thioester reductase activity
and resembled the corresponding mutant overexpressing native Oar1p for the above-mentioned phenotype characteristics. This is
the ﬁrst identiﬁcation of a metazoan 3-oxoacyl-thioester reductase (see Note Added in Proof).
Copyright © 2009 Aner Gurvitz.ThisisanopenaccessarticledistributedundertheCreativeCommonsAttributionLicense,which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Eukaryotes have long been thought to undertake de novo
fatty acid biosynthesis exclusively in their cytosol. This
acyl carrier protein-(ACP-) dependent process relies on a
single associative type 1 fatty acid synthase (FASI), which
accommodates all the necessary enzyme activities. However,
this traditional view has since been updated following the
discovery of an additional mitochondrial FASII in yeast and
mammals (reviewed in [1, 2]). FASII represents a dissociated
system in which each of the enzyme activities occurs within a
discrete protein. Although all of the fungal—and most of the
mammalian—FASII constituents have been identiﬁed, the
metazoan 3-oxoacyl-ACP reductase component has hitherto
not been reported.
The present work is concerned with identifying the
nematode mitochondrial FASII enzyme corresponding to 3-
oxoacyl-ACP reductase. The C. elegans genome has been
fully sequenced [5], and a cursory glance at the databases
(WormBase, http://www.wormbase.org/) reveals that the
nematode contains numerous enzymes with amino acid
similarities to the mitochondrial 3-oxoacyl-ACP reductase
Oar1p of Saccharomyces cerevisiae FASII [6]. In S. cerevisiae,
FASII is critical for mitochondrial function and morphology,
and a lesion to any one of the genes encoding FASII proteins
results in a respiratory growth phenotype, underdeveloped
mitochondrialackingcytochromesand,insomecases,lossof
mitochondrial DNA [1, 2]. Here, S. cerevisiae was employed
as a heterologous system for determining whether any of the
candidate nematode proteins might represent a mitochon-
drial 3-oxoacyl-ACP reductase,by monitoring their ability to
replace fungal Oar1p. S. cerevisiae oar1Δ cells heterologously
expressing an active nematode 3-oxoacyl-thioester reductase
were compared to an otherwise isogenic strain relying on
an ectopically expressed native reductase for growth on
glycerol, respiration, and lipoic acid production. The results
in yeast are discussed with reference to the potential for a
dysfunctional FASII in extending nematode lifespan.2 Journal of Biomedicine and Biotechnology
Table 1: Plasmids and oligonucleotides used.
Plasmids or oligonucleotides Description Source/reference
Plasmid
a
(1) pBluescript KS II (+) pKS cloning vector Stratagene
pKS:F09E10.31 F09E10.3 in pBluescript This study
pKS:D1054.81 D1054.8 in pBluescript This study
(2) YEp352 URA3-marked multicopy plasmid [3]
(3) YEp:CTA12 CTA1 behind its own promoter [4]
YEp:F09E10.33 F09E10.3 behind the CTA1 promoter This study
YEp:D1054.83 D1054.8 behind the CTA1 promoter This study
YEp:OAR13 OAR1 behind the CTA1 promoter Z.-J. Chen
oligonucleotideb
Ce OAR1-1 5  XbaI TTATTCTAGATGAGTGCTTTGCTGGGAGG This study
Ce OAR1-1 3  XhoI TATTCTCGAGCTACATACTAAATCCACCGG This study
Ce OAR1-2 5  XbaI TTATTCTAGATGACTCGTTTTGCTGAAAAAGTC This study
Ce OAR1-2 3  XhoI TATTCTCGAGTTAATGTAAAAGTTTTGCAAAG This study
aThe superscripts following the plasmid designations refer to their parental vectors, for example, pKS:F09E10.31 was derived from (1) pBluescript KS II (+).
bOligonucleotides Ce OAR1-1 refer to F09E10.3 and Ce OAR1-2 to D1054.8.
2.MaterialsandMethods
2.1. S. cerevisiae Strain, Plasmids, and Oligonucleotides.
Plasmids and oligonucleotides used are outlined in Table 1.
The Escherichia coli strain TOP10 F
  was used for
all plasmid ampliﬁcations and isolations. The mutant
yeast strain BY4741oar1Δ (MATa his3Δ1l e u 2 Δ0m e t 1 5 Δ0
ura3Δ0 ykl055c::kanMX) was purchased from EUROSCARF
(http://www.uni-frankfurt.de/). Expression plasmids were
introduced into BY4741oar1Δ cells using a published
method [7], and transformants were enriched on solid SD-
Ura medium, described below.
2.2. Plasmid Constructions. DNA work and plasmid assem-
bly were undertaken according to standard methods [8].
The F09E10.3 and D1054.8 genes were isolated from cDNA
by polymerase chain reaction using Phusion high ﬁdelity
DNA polymerase (Finnzymes Oy, Espoo, Finland) and
the appropriate oligonucleotide pairs (Table 1). Subsequent
processing of the resultant amplicons, including their elec-
trophoresis, puriﬁcation, and insertion into an EcoRV-
digested pBluescript plasmid vector (Stratagene, La Jolla,
CA) was performed as described [9]. The pBluescript inserts
were isolated following digestion with XbaIa n dXhoIr e s t r i c -
tion enzymes, and ligated behind the CTA1 promoter to
pYE352:CTA1 [4] from which the CTA1 open reading frame
encoding yeast peroxisomal catalase A was removed using
the same enzymes. Sequencing of insert nucleotides ensured
that no mutations were introduced during the ampliﬁcation
process. Construction of plasmid YEp352:OAR1 expressing
yeast OAR1 behind the CTA1 promoter will be described
elsewhere. (See Note Added in Proof).
2.3. Media, Growth, Enzyme Assays, Respiration Competence
and Lipoic Acid Measurements. Standard media were pre-
pared for yeast [10]a n dE. coli [11]. Episomal plasmids
based on the URA3-marked YEp352 plasmid vector [3]w e r e
retained in transformed S. cerevisiae strains by applying
selective pressure using solid SD-Ura medium consisting of
0.67% (wt/vol) yeast nitrogen base without amino acids, 2%
(wt/vol) D-glucose, 3% (wt/vol) agar, and with all necessary
supplements added except for uracil (Sigma-Aldrich Inc, St.
Louis, MO USA). Solid synthetic complete glycerol medium
(SCglycerol) was prepared essentially as the aforementioned
SD-Ura medium, with the exceptions that uracil was added
and glucose was replaced with 3% (wt/vol) glycerol as the
sole carbon source.
For high levels of protein expression prior to enzyme
assays, yeast cells were grown on oleic acid medium as
described [12] .C e l l sw e r eb r o k e nw i t hg l a s sb e a d si na
buﬀer consisting of 50mM KPi (pH 7.0), 200mM KCl, and
0.1% (wt/vol) Triton X-100. Protein concentrations [13]
and reductase activities [14] were determined as described.
The reductase activity assay mixture consisted of 50mM
KPi (pH 8.0) and 50μg/mL bovine serum albumin, 2.0μL
puriﬁed protein representing the hydratase 2 domain from
human MFE2 (1/10 dilution of a 3mg/ml stock), 125μM
NAD+ or NADP+,a n d6 0 μM2 - trans-hexenoyl-CoA [15].
In this assay, the reverse reaction was monitored, whereby
the 2-trans-hexenoyl-CoA substrate was ﬁrst hydrated by
the aforementioned hydratase 2 domain of human MFE2
into the 3-hydroxyacyl-CoA, followed by the removal of
two electrons from C3 by 3-oxoacyl-thioester reductase
leaving behind a carbonyl group within the 3-oxoacyl-CoA
product. To improve the sensitivity of the reductase assay,
which was designed to be performed on crude extracts,
the coincidental reduction of NAD+ or NADP+ into the
corresponding NAD(H) and NADP(H) species was moni-
tored spectrophotometrically at 340–385nm, instead of just
340nm, using a dual wavelength spectrophotometer (Shi-
madzu Corp., Kyoto, Japan) [16]. Respiration competence
was monitored using an overlay consisting of 0.1% (wt/vol)
2,3,5-triphenyltetrazolium chloride (TTC) in phosphate-
buﬀered saline and 1.5% (wt/vol) low-melting temperature
agarose [17].Journal of Biomedicine and Biotechnology 3
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Figure 1: Similarity of the C. elegans D1054.8 and F09E10.3 gene products to their bacterial or yeast homologues, FabG and YKL055c
(Oar1p), respectively. Comparison of the deduced amino acid sequences was undertaken using Multalin and Genedoc. Dashes indicate the
arrangement of the sequences for best ﬁt. Black shadings refer to strictly conserved amino acid residues among all four sequences whereas
the darker and lighter grey shadings denote regions with more relaxed residue similarities not necessarily shared by the full set of sequences.
MitoProt predictions of cleaved sequences are indicated (D1054.8, ∗; F09E1.03, +). The catalytic triad of FabG consisting of the amino acid
residues serine 148 (S), tyrosine 151 (Y), and lysine 155 (K) are shown in bold below the sequences. Accession numbers used were FabG;
AP 001719; D1054.8, CAA98438; F09E10.3, AAB52488; YKL055c, P35731.
The content of lipoic acid in yeast strains was estimated
using a biological assay relying on lipoic acid-deﬁcient
bacterial cells described previously [18, 19]. The assay
determined the growth of these defective bacterial cells in
liquid medium to which extracts were added that were
generated from control and tester yeast strains, and the
growth values were converted to the amount of lipoic acid
present in the yeast cells based on a standard curve. Each
yeaststrain was grown in triplicates for 48h in liquid SD-Ura
medium selecting for plasmid presence. Acid hydrolysis was
carried out in 0.5ml 9N H2SO4,a n dE. coli JRG33 (lipA9)
cultures were inoculated to an initial OD600 of 0.015 in 2ml
of 1 × basal growth medium [20] containing 50mM sodium
succinate and grown for 36–48h.
2.4. Mitochondrial Localisation Predictions and Sequence
Comparisons. MitoProt(http://www.mips.biochem.mpg.de/
cgi-bin/proj/medgen/mitoﬁlter), PSORTII(http://psort.ims
.u-tokyo.ac.jp/form2.html), and TargetP (http://www.cbs
.dtu.dk/services/TargetP/) were used to calculate the N-ter-
minal region of proteins that could support a mitocho-
ndrial targeting sequence [21, 22] and Multalin(http://
npsa-pbil.ibcp.fr/cgi-bin/npsa automat.pl?page=/NPSA/np-
sa multalin.html) and Genedoc (http://www.nrbsc.org/gfx/
genedoc/index.html) to generate the sequence comparison
in Figure 1.
3. Results
3.1. Selection of Nematode F09E10.3 and D1054.8 for Analysis.
The WormBase homology group identiﬁer KOG1200, which
refers to “mitochondrial/plastidial beta-ketoacyl-ACP reduc-
tases” (3-oxoacyl-ACP reductases), lists Y39A1A.11/dhs-11
and F09E1.03/dhs-25 as potentially encoding this activity
in the nematode. However, there are approximately 28
additional genes annotated with the dhs designation (alco-
hol dehydrogenase/short chain). Moreover, the C. elegans
genome contains a multitude of genes whose products are
homologous to yeast mitochondrial Oar1p. To determine
which of these genes might encode proteins residing in
mitochondria, the MitoProt (MP), PSORT II (PS), and
TargetP (TP) algorithms were used to analyze the deduced
amino acid sequences of the candidate genes, resulting in
a prediction that the sequence relating to F09E10.3 (MP,
0.9119; PS, 0.1; TP, 0.540) had a probability of representing a
mitochondrial protein that was equivalent to or higher than
that calculated for the known yeast mitochondrial protein
Oar1p (0.9166, 0.1, 0.244). In addition to F09E10.3, D1054.8
(0.9232, 0.439, 0.505) was also selected for investigation as
it was previously chronicled as the sole potential FASII-
like 3-oxoacyl-ACP reductase gene whose RNAi inactivation
aﬀected worm longevity [23]. The conceptual translation
products of both D1054.8 and F09E10.3 contained amino
acid residues that appeared to correspond to the catalytic
triad previously characterized in bacterial FabG [24], albeit
only within the amino acid sequence encoded by the latter
nematode gene was the distance across the triad region fully
conserved (Figure 1).
3.2. Nematode F09E10.3 Restores Respiratory Growth to Yeast
oar1Δ Cells. To determine whether F09E10.3 or D1054.8
might code for 3-oxoacyl-ACP reductases, the genes were
expressed behind the promoter of yeast CTA1 encoding
peroxisomal catalase A (Cta1p), which is only moderately
derepressed on nonfermentable carbon sources such as
glycerol, used here for complementation assays. On glycerol
medium, yeast cells shift their metabolism to respiration,
which requires an operational FASII within functional
mitochondria [1, 2]. An extra fungal mitochondrial leader
sequence was not fused to the nematode proteins. Yeast4 Journal of Biomedicine and Biotechnology
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Figure 2: Phenotype rescue of a yeast oar1Δ strain expressing
F09E10.3. Mutant S. cerevisiae BY4741oar1Δ cells producing native
mitochondrial Oar1p (positive control), peroxisomal catalase A
Cta1p (negative control), or the nematode mitochondrial protein
F09E10.3 (tester strain), were grown on SD-Ura medium selecting
for plasmid presence, and following tenfold serial dilution (tri-
angle) were spotted onto the indicated solid media. Respiration
competence was examined by applying 2,3,5-triphenyltetrazolium
chloride (TTC) as an overlay to the SD-Ura medium.
oar1Δ mutant cells were transformed with plasmids express-
ing fungal Oar1p (positive control), native Cta1p (negative
control), or each of the nematode F09E10.3 or D1054.8 pro-
tein products and were applied to solid SCglycerol medium.
This demonstrated that only cells expressing F09E10.3 or
OAR1 could grow and divide (see below).
To assess the eﬃciency of the nematode F09E10.3 protein
at replacing yeast Oar1p, the aforementioned transformants
were propagated on SD-Ura medium, and following tenfold
serial dilution, cultures were spotted onto SD-Ura or SCglyc-
erolmedia,andtheplateswereincubatedat30
◦Cuntilsingle
colonies were detectable. The results in Figure 2 demon-
strated that like the situation with the self-complemented
strain, mutant cells expressing F09E10.3 could thrive on
glycerol, whereas those mutant cells expressing CTA1 were
not able to proliferate on this medium type. Hence, the
respiratory-deﬁcient phenotype of mutant oar1Δ cells was
rescued following the expression of F09E10.3, indicating
functional complementation.
Yeastcellslacking the nativeOAR1 gene have been shown
before to lack assembled cytochrome complexes [6], and
so their rehabilitation to normal respiratory growth was
expected to occur contemporaneously with the assembly of
cytochrome complexes and the regeneration of the electron
transport chain. To examine whether mutant cells expressing
Oar1p or the F09E10.3 protein contained a regenerated
electron transfer chain, respiration competence was assayed
by applying to the cells spotted onto solid SD-Ura medium
an overlay consisting of 2,3,5-triphenyltetrazolium chloride
(TTC). The results revealed that only mutant oar1Δ cells
expressing Oar1p or the F09E10.3 protein could rapidly
metabolize TTC to generate the red chromophore, whereas
those expressing Cta1p were essentially white (lower panel;
Figure 2).
3.3.Yeastoar1ΔCellsExpressingF09E10.3Contain3-Oxoacyl-
Thioester Reductase Activity. FASII enzyme activities can
often be measured in soluble protein extracts made from
mutant yeast cells ectopically expressing heterologous pro-
teins. For example, enzyme activities for 2-trans-enoyl-
thioester reductase can be detected in protein extracts
made from yeast etr1Δ mutant cells producing S. cerevisiae
Etr1p [25], Candida tropicalis Etr1p or Etr2p [25, 26], and
Mycobacterium tuberculosis InhA [9]. However, other FASII
enzyme activities are less amenable to detection using this
procedure. Although discernible levels of 3-hydroxyacyl-
thioester dehydratase activity can be measured in extracts
made from yeast htd2Δ mutants producing mycobacterial
HadAB, HadBC, HtdX, HtdY, and HtdZ [27, 28], the sole
documented measurement of dehydratase activity in mutant
cells enriched for native Htd2p could only be undertaken
following the laborious preparation of pure mitochondria
[29].
To examine whether the F09E10.3 protein contained
reductaseactivity,yeastcellsweregrownintriplicatecultures
on oleic acid medium [12] under which conditions the
CTA1 promoter is highly induced [30]. Oleic acid has
not been shown previously to interfere with yeast FASII
[9, 25, 27, 28]. The cells were broken with glass beads,
and the ensuant soluble protein extracts were subjected
to spectrophotometric analysis for reductase activity (in
the reverse orientation), which ostensibly could depend
on either NAD+ or NADP+ as co-factor. Enzyme assays
performed on extracts from oar1Δ cells over-expressing
native Oar1p, a presumed NADP+-dependent enzyme, did
not yield appreciable levels of activity using the present
assay. Likewise, mutant cells over-expressing Cta1p also
failed to produce extracts with a speciﬁc reductase activity.
On the other hand, soluble protein extracts obtained from
mutant cells over-expressing the F09E10.3 protein gave rise
to an NAD+-dependent oxidation of the 2-trans-hexenoyl-
CoA substrate at the rate of 0.97 ± 0.18 (S.D., n = 3)Journal of Biomedicine and Biotechnology 5
μmol/mg protein xmin
−1. NADP+ did not act as co-factor
when examining the nematode protein for reductase activity.
Hence, ectopic expression of C. elegans F09E10.3 in yeast
oar1Δ mutant cells resulted in clearly discernible levels of
catalytic activity in an assay designed to expose 3-oxoacyl-
thioester reductases.
3.4. Expression of F09E10.3 Restores Lipoic Acid Production
in the oar1Δ Mutant. Lastly, to couple the expression of
the F09E10.3 protein with fatty acid biosynthesis in yeast
mitochondria, lipoic acid synthesis was measured in these
strains. The results showed that the negative control strain
(oar1Δ cells expressing peroxisomal catalase A) yielded
extracts supporting only a minimal growth level of the
mutant bacterial cells that was equivalent to 25±3n gl i p o i c
acid per gram wet weight yeast cells, whereas levels of
lipoic acid in mutant cells expressing fungal Oar1p or the
nematode F09E10.3 protein gave rise to a bacterial growth
that corresponded to 138±22 or 80±4n gl i p o i ca c i dp e r
or gram wet weight, respectively. Hence, the combined
results demonstrated that mutant oar1Δ cells could grow
on glycerol since their formerly defective mitochondrial
functions were restored due to the expression of the full-
length F09E10.3 protein, indicating that it represented a
putative mitochondrial 3-oxoacyl-thioester reductase.
4. Discussion
The present study demonstrated a physiological function for
the gene product of C. elegans F09E10.3/dhs-25 as a possible
3-oxoacyl-thioester reductase of mitochondrial FASII. The
F09E10.3 protein could reach its designated subcellular
compartment in fungi without resorting to a dedicated
yeast mitochondrial targeting sequence, so as to replace the
native mitochondrial 3-oxoacyl-ACP reductase Oar1p in S.
cerevisiae oar1Δ cells. The eﬃciency of this interchange was
underscored by monitoring F09E10.3-complemented yeast
mutant cells for respiratory growth on glycerol medium,
metabolism of TTC, and synthesis of lipoic acid. Although
the corresponding FASII protein in protozoans has been
exposed previously, for example, Plasmodium falciparum
FabG was crystallized and characterized enzymatically [31]
and potential Oar1p homologues in Trypanosome brucei
were shown to be mitochondrial [32], F09E10.3 represents
the ﬁrst metazoan 3-oxoacyl-thioester reductase gene to be
positively identiﬁed (see Note Added in Proof). WormBase
reports no RNAi phenotypes for F09E10.3, but this could be
due to redundancy as the result of additional mitochondrial
reductases not yet disclosed.
Although all previously studied 3-oxoacyl-thioester
reductases have been shown to depend on NADP(H) for
catalysis, the ﬁnding that the F09E10.3 protein relied on
NAD(H) was not altogether surprising. This is because other
mitochondrial enzyme activities, such as isocitrate dehydro-
genase, are also known to require each of these two cofactors.
WormBase lists at least 10 potential NAD(H)-dependent
and an additional 10 potential NADP(H)-dependent isoc-
itrate dehydrogenases (gene onthologies GO:0004449 and
GO:0004450, resp.). It is tempting to speculate that future
studies will uncover additional 3-oxoacyl-thioester reduc-
tases in metazoan mitochondria that would similarly depend
on NAD(H) rather than on NADP(H).
The role of mitochondrial processes in aﬀecting nema-
tode longevity has been studied extensively using RNAi
technology [23, 33, 34]. Dysfunctional mitochondrial activ-
ities that have been previously linked to a prolonged
nematodelifespaninclude theelectrontransportchain,RNA
editing, and cytochrome complex formation. However, since
mitochondrial FASII has hitherto not been identiﬁed in
nematodes, its involvement in C. elegans lifespan extension
could not be speciﬁcally addressed. If the lifespan extension
observed with the RNAi intervention of C. elegans W09H1.5
[23], which encodes a potential homologue of the afore-
mentioned yeast Etr1p, is in any way indicative, then a
dysfunctional mitochondrial FASII might be conducive to
longer nematode life. Worm longevity notwithstanding, the
issue is that yeast FASII mutants will likely continue to play
an important role in exposing FASII enzymes in metazoan
mitochondria.
Note Added in Proof. Identiﬁcation of human NAD(H)-
dependent 3-oxoacyl-ACP reductase, HsKAR, of mitochon-
drial FASII, and the description of pYE352:OAR1 have been
published online [35].
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